BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 7914535)

  • 1. Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals.
    Tian L; Prior C; Dempster J; Marshall IG
    J Physiol; 1994 May; 476(3):517-29. PubMed ID: 7914535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prejunctional modulation of acetylcholine release from the skeletal neuromuscular junction: link between positive (nicotinic)- and negative (muscarinic)-feedback modulation.
    Vizi ES; Somogyi GT
    Br J Pharmacol; 1989 May; 97(1):65-70. PubMed ID: 2720313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium.
    Plomp JJ; van Kempen GT; Molenaar PC
    J Physiol; 1994 Jul; 478 ( Pt 1)(Pt 1):125-36. PubMed ID: 7965828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenthonium, a quaternary derivative of (-)-hyoscyamine, enhances the spontaneous release of acetylcholine at rat motor nerve terminals.
    Fann ML; Souccar C; Lapa AJ
    Br J Pharmacol; 1990 Jul; 100(3):441-6. PubMed ID: 2390670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings.
    Redman RS; Silinsky EM
    J Physiol; 1994 May; 477(Pt 1):117-27. PubMed ID: 8071878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tubocurarine on end-plate current rundown and quantal content during rapid nerve stimulation in the snake.
    Harborne AJ; Bowman WC; Marshall IG
    Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):479-90. PubMed ID: 3271621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation by tonic A2a-adenosine receptor activation of CGRP-facilitated [3H]-ACh release from rat motor nerve endings.
    Correia-de-Sá P; Ribeiro JA
    Br J Pharmacol; 1994 Feb; 111(2):582-8. PubMed ID: 8004402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic agonists antagonize quantal size increases and evoked release at frog neuromuscular junction.
    Van der Kloot W
    J Physiol; 1993 Aug; 468():567-89. PubMed ID: 8254525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic depression in frog neuromuscular junction.
    Glavinović MI
    J Neurophysiol; 1987 Jul; 58(1):230-46. PubMed ID: 2441003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of nerve section on the non-quantal release of ACh from the motor nerve terminal.
    Stanley EF; Drachman DB
    Brain Res; 1986 Feb; 365(2):289-92. PubMed ID: 3004659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism by tubocurarine and verapamil of the regenerative acetylcholine release from mouse motor nerve.
    Hong SJ; Chang CC
    Eur J Pharmacol; 1989 Mar; 162(1):11-7. PubMed ID: 2721560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A correlation between quantal content and decay time of endplate currents in frog muscles with intact cholinesterase.
    Giniatullin RA; Khazipov RN; Vyskocil F
    J Physiol; 1993 Jul; 466():95-103. PubMed ID: 8410718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological and regenerative acetylcholine release from motor nerve: differential inhibitions by vesamicol and omega-agatoxin IVA.
    Hong SJ; Lee SH; Chang CC
    Neuroscience; 1995 Jul; 67(1):169-75. PubMed ID: 7477897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Ca2+ uptake prevents desynchronization of quantal release and minimizes depletion during repetitive stimulation of mouse motor nerve terminals.
    David G; Barrett EF
    J Physiol; 2003 Apr; 548(Pt 2):425-38. PubMed ID: 12588898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prejunctional actions of muscle relaxants: synaptic vesicles and transmitter mobilization as sites of action.
    Prior C; Tian L; Dempster J; Marshall IG
    Gen Pharmacol; 1995 Jul; 26(4):659-66. PubMed ID: 7635241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.
    Hong SJ; Chang CC
    Br J Pharmacol; 1991 Apr; 102(4):817-22. PubMed ID: 1677297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic differences in the effect of calcium on quantal and non-quantal acetylcholine release at the murine diaphragm.
    Nikolsky EE; Voronin VA; Vyskocil F
    Neurosci Lett; 1991 Feb; 123(2):192-4. PubMed ID: 2027533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciguatoxin enhances quantal transmitter release from frog motor nerve terminals.
    Molgó J; Comella JX; Legrand AM
    Br J Pharmacol; 1990 Apr; 99(4):695-700. PubMed ID: 1972891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular transmission in a mammalian preparation in the absence of blocking drugs and the effect of D-tubocurarine.
    Hubbard JI; Wilson DF
    J Physiol; 1973 Jan; 228(2):307-25. PubMed ID: 4346989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.